Ventyx Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $207,994,000.
Profit Margin
| 2019 | 0 | -4.47M | |
|---|---|---|---|
| 2020 | 0 | -28.53M | |
| 2021 | 0 | -78.36M | |
| 2022 | 0 | -107.95M | |
| 2023 | 0 | -192.96M |
VTYX Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 941K | 470K | 30K | 0 | 0 |
Gross profit | -941K | -470K | -30K | 0 | 0 |
Operating exp. | |||||
Research and development | 175.76M | 87.73M | 58.48M | 6.36M | 3.55M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 207.99M | 113.13M | 67.14M | 7.05M | 4.18M |
Operating income | -207.99M | -113.13M | -67.14M | -7.05M | -4.18M |
Other income (expenses), net | 15.03M | 4.71M | -16.59M | -21.12M | -147K |
Income before tax | -192.96M | -108.42M | -83.74M | -28.17M | -4.32M |
Income tax expense | 0 | -470K | -5.38M | 358K | 146K |
Net income | -192.96M | -107.95M | -78.36M | -28.53M | -4.47M |
Earnings per share | |||||
Basic EPS | -3.3 | -2.06 | -1.55 | -0.57 | -0.08 |
Diluted EPS | -3.3 | -2.06 | -1.55 | -0.57 | -0.08 |
| Data source | Data source | Data source |